1  constitute a good vaccine candidate against erysipelas.

2 gen causing infections, such as tonsillitis, erysipelas, and sepsis.

3  diverse range of invasive disease episodes (erysipelas, cellulitis, pneumonia, bacteremia, septic ar

4 of primary lymphedema, infection (cellulitis/erysipelas), Crohn's disease, obesity, cancer, and cance

5 mportant veterinary pathogen responsible for erysipelas in swine and a variety of diseases in animals

6 and skin-structure infections (cellulitis or erysipelas, major cutaneous abscess, or wound infection)

7 nfections (ABSSSIs), including cellulitis or erysipelas, major cutaneous abscesses, and wound infecti

8 gested to be associated with protection from erysipelas (n = 278) and streptococcal tonsillitis (n =

9 (BMI >/=30): HR = 3.64, 95% CI: 1.62, 8.18), erysipelas (obesity: HR = 5.19, 95% CI: 3.38, 7.95), and

10  symptoms, and cellulitis other than typical erysipelas were predictors of nonresponse at day 3.